| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.867 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.867 |
| Total Expenses - EUR | 2.239 | 3.201 | 19.393 | 13.581 | 110 | 6.172 | 3.126 | 3.307 | 3.735 | 6.758 |
| Gross Profit/Loss - EUR | -2.239 | -3.201 | -19.393 | -13.581 | -110 | -6.172 | -3.126 | -3.307 | -3.735 | 3.109 |
| Net Profit/Loss - EUR | -2.239 | -3.201 | -19.393 | -13.581 | -110 | -6.172 | -3.126 | -3.307 | -3.735 | 2.960 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Neuroclinica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 27.952 | 27.667 | 10.878 | 75 | 74 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 0 | 0 | -6 | -6 | -6 | -4 | 16 | -4 | 0 | 7.307 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 914 |
| Cash | 0 | 0 | -6 | -6 | -6 | -4 | 16 | -4 | 0 | 6.393 |
| Shareholders Funds | -10.723 | -13.815 | -32.926 | -45.903 | -45.124 | -50.441 | -52.448 | -55.918 | -59.484 | -56.191 |
| Social Capital | 63 | 62 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 38.675 | 41.481 | 43.799 | 45.972 | 45.192 | 50.437 | 52.465 | 55.913 | 59.483 | 63.498 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8610 - 8610" | |||||||||
| CAEN Financial Year |
8610
|
|||||||||
Comments - Neuroclinica Srl